Moderna Inc (MRNA)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$29.21
Buy
$29.33
$-0.17 (-0.57%)
Prices updated at 13 Dec 2025, 00:59 EST
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 6,754m | 3,199m | |
| 2,061m | 1,735m | |
| -4,239m | -3,945m | |
| -62.76 | -123.32 | |
| -4,714m | -3,561m | |
| -3,283m | -3,394m | |
| Sales, General and administrative | 1,549m | 1,174m |
| Interest expenses | 38m | 24m |
| Provision for income taxes | 772m | -46m |
| Operating expenses | 6,300m | 5,680m |
| Income before taxes | -3,942m | -3,607m |
| Net income available to common shareholders | -4,714m | -3,561m |
| -12.33 | -9.28 | |
| Net interest income | 383m | 401m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -12.33 | -9.28 |
| Free cash flow per share | -6.8435 | -10.3357 |
| Book value/share | 35.2225 | 30.899 |
| Debt equity ratio | 0.087917 | 0.065132 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 10,325m | 8,099m |
| Current liabilities | 3,015m | 2,206m |
| Total capital | 13,854m | 10,901m |
| Total debt | 1,243m | 747m |
| Total equity | 13,854m | 10,901m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 18,426m | 14,142m |
| Total liabilities | - | - |
| Cash and cash equivalents | 2,907m | 1,927m |
| Common stock | 382m | 386m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 3,217m | 2,928m |
| Cash dividends paid | - | - |
| -3,825m | -4,055m | |
| Investments (gains) losses | 4,206m | 1,949m |
| 2,928m | 1,929m | |
| Net income | - | - |
| -3,118m | -3,004m | |
| -707m | -1,051m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
